跳至主要内容
临床试验/RBR-22bdqcc
RBR-22bdqcc进行中(未招募)Unknown

Chemotherapy-induced oral side effects: evaluation, characterization, and management proposals in oncology patients at São Vicente de Paulo Hospital in Guarapuava

Universidade Estadual do Centro Oeste0 个研究点目标入组 107 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
107

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 0(—)

入选标准

  • Pacientes oncológicos; de ambos os sexos; que iniciaram o ciclo terapêutico com ácido zoledrônico (Zometa®) no período compreendido entre janeiro de 2023 e dezembro de 2024, independentemente da continuidade da terapia em anos subsequentes

排除标准

  • Patients who progressed to death; or who present severe systemic debility (as documented in the medical records) that prevents in-person participation

研究者

相似试验

How to care for oral health during chemotherapy: a... | 临床试验